SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Chemed Corp. – ‘8-K’ for 8/5/22

On:  Friday, 8/5/22, at 2:04pm ET   ·   For:  8/5/22   ·   Accession #:  1562762-22-343   ·   File #:  1-08351

Previous ‘8-K’:  ‘8-K’ on / for 7/27/22   ·   Next:  ‘8-K’ on / for 10/31/22   ·   Latest:  ‘8-K’ on / for 4/17/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/05/22  Chemed Corp.                      8-K:5       8/05/22   10:179K                                   Certent, Inc./FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     62K 
 5: R1          Document And Entity Information                     HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- che-20220805x8k_htm                 XML     15K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- che-20220805_lab                      XML     58K 
 4: EX-101.PRE  XBRL Presentations -- che-20220805_pre               XML     33K 
 2: EX-101.SCH  XBRL Schema -- che-20220805                          XSD     11K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    17K 
10: ZIP         XBRL Zipped Folder -- 0001562762-22-000343-xbrl      Zip     12K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C: 
  che-20220805x8k  
 i false i 000001958400000195842022-08-052022-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM  i 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported):

 i August 5, 2022

 i CHEMED CORPORATION

(Exact name of registrant as specified in its charter)

 i Delaware

      i 1-8351

   i 31-0791746

(State or other
jurisdiction of
incorporation)

(Commission File Number)

(I.R.S. Employer
Identification
Number)

 i 2600 First Financial Center,  i 255 East 5th Street,  i Cincinnati,  i OH  i 45202

(Address of principal executive offices)             (Zip Code)

Registrant's telephone number, including area code:

( i 513)  i 762-6690

 

Title of each class

 

Trading symbol

Name of each exchange on which

registered

 i Capital stock $1 par value

 i CHE

 i NYSE

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 i [_]     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 i [_]     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240-14a-12)

 i [_]     Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240-14d-2(b))

 i [_]     Pre-commencement communications pursuant to Rule 13e-4 (c) under Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.  Emerging growth company  i [_]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]


Page 1 of 4


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Donald E. Saunders provided notice of his retirement from the Board of Directors of Chemed Corporation (the “Corporation”), effective as of 5:00 ET August 5, 2022. The Corporation is filing the information under this item pursuant to Item 5.02(b).

On August 5th, 2022, the Board of Directors of the Corporation appointed John M. Mount, Jr. to the Board, Mr. Mount is the North America Sports and Entertainment Marketing Team Lead at the Coca-Cola Company.

At this time, the Board of Directors has not made any determination as to any committees on which Mr. Mount is expected to serve. Mr. Mount will receive the same compensation as the other non-employee members of the Board of Directors. The Corporation’s Director compensation program is described in the Corporation’s definitive proxy statement dated April 8, 2022.

There have not been any related person transactions with Mr. Mount, and there are no arrangements or understandings between Mr. Mount and any other person, pursuant to which Mr. Mount was elected as a director of the Corporation.


Page 2 of 4


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CHEMED CORPORATION

Dated:   August 5, 2022

By:

/s/ Michael D. Witzeman

Michael D. Witzeman

Vice President and Controller

Page 3 of 4


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:8/5/22
4/8/22DEF 14A
 List all Filings 
Top
Filing Submission 0001562762-22-000343   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 23, 11:23:46.1am ET